Efficiency Study of the EUS-FNA Needles With & Without a Side Port in

Status Recruiting

Clinical Trial Summary

For diagnosis of pancreatic tumors, endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration (EUS-FNA) are well established techniques in clinical practice. We hypothesize that a FNA needle with a side port could improve the diagnostic yield. The aim of this prospective randomized study is to determine whether there is a difference in diagnostic yield in patients with pancreatic masses for evaluation.

Clinical Trial Description

For diagnosis of pancreatic tumors, endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration (EUS-FNA) are well established techniques in clinical practice. In the case of EUS, an ultrasonic transducer located at the tip of the echoendoscope allows the endoscopist to visualize the wall of gastrointestinal tract as a series of definable layers corresponding to histology, and also enables detailed images of areas outside of the digestive tract. EUS has a significant clinical impact because it allows assessment of submucosal GI lesions, loco-regional staging of gastrointestinal malignancy, tissue diagnosis by EUS-FNA and staging of pancreaticobiliary lesions, non-small-cell lung carcinoma, and mediastinal disease. In prospective trials, EUS-FNA has been clearly established to be an important diagnostic tool with excellent safety profile.

Olympus has recently made commercially available a new 22 gauge FNA needle with a side port at the needle tip to facilitate the process of FNA and increase the diagnostic yield. There have been preliminary unpublished retrospective data that suggested the yield might be raised. However, there are no prospective multicenter randomized controlled studies to ascertain the validity of the assumption. The aim of this prospective randomized study is to determine whether there is a difference in diagnostic yield between EZ-Shot 2 (model: NA-220H-8022) and EZ-Shot 2 with side port (NA-230H-8022) in patients with pancreatic masses for evaluation. We hypothesize that a FNA needle with a side port could improve the diagnostic yield. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01978808
Study type	Observational
Source	National Taiwan University Hospital
Contact	Tsu-Yao Cheng
Phone	+886-2-23123456
Email	tycheng@ntu.edu.tw
Status	Recruiting
Phase	N/A
Start date	October 2013
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01673334` - Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms	Phase 4
Completed	`NCT01479803` - Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS	Phase 3
Completed	`NCT02716207` - Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife	N/A
Withdrawn	`NCT01434550` - Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer	N/A
Completed	`NCT03444051` - Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors	N/A
Recruiting	`NCT05794048` - METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors	N/A
Recruiting	`NCT05871164` - Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
Recruiting	`NCT03558945` - Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor	Phase 1
Recruiting	`NCT01969110` - Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy	Phase 4
Completed	`NCT02330497` - Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor	N/A
Completed	`NCT01692873` - Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors	N/A
Recruiting	`NCT04075305` - The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Recruiting	`NCT04357483` - Effect of Thrombin-containing Collagen-based Hemostatic Matrix	Phase 4
Recruiting	`NCT01698190` - Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions	N/A
Completed	`NCT03340844` - Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors	N/A
Withdrawn	`NCT02534246` - Head to Head Comparison of Two Needles EUS Guided FNB	N/A
Not yet recruiting	`NCT01819961` - Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery	Phase 4
Withdrawn	`NCT02269683` - Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms